Clinicopathologic features of ovarian mixed mesodermal tumors and carcinosarcomas
dc.contributor.author | Terada, Keith Y. | en_US |
dc.contributor.author | Johnson, Terri L. | en_US |
dc.contributor.author | Hopkins, Michael P. | en_US |
dc.contributor.author | Roberts, James A. | en_US |
dc.date.accessioned | 2006-04-07T20:54:07Z | |
dc.date.available | 2006-04-07T20:54:07Z | |
dc.date.issued | 1989-02 | en_US |
dc.identifier.citation | Terada, Keith Y., Johnson, Terri L., Hopkins, Michael, Roberts, James A. (1989/02)."Clinicopathologic features of ovarian mixed mesodermal tumors and carcinosarcomas." Gynecologic Oncology 32(2): 228-232. <http://hdl.handle.net/2027.42/28069> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6WG6-4GWTBRM-H/2/78c499dcc033a34f4779bc5985e2fc53 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/28069 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=2535999&dopt=citation | en_US |
dc.description.abstract | Over a 27-year period there were 15 patients treated at the University of Michigan Medical center for carcinosarcomas or mixed mesodermal tumors of the ovary. Overall median survival was 11 months. Median survival was 4 months in patients with carcinosarcomas and 13 months in patients with mixed mesodermal tumors (P = 0.066). Patients with a chondrosarcomatous element had a significantly longer median survival than patients with mixed mesodermal tumors lacking cartilaginous differentiation (P = 0.031). The presence of a rhabdomyosarcomatous element did not affect survival. The size of the primary tumor, presence of ascites, FIGO stage, and degree of initial resection (optimal versus suboptimal) did not affect survival. There was no difference in survival between patients receiving postoperative chemotherapy and patients undergoing postoperative irradiation. | en_US |
dc.format.extent | 5309205 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Clinicopathologic features of ovarian mixed mesodermal tumors and carcinosarcomas | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Public Health | en_US |
dc.subject.hlbsecondlevel | Otolaryngology | en_US |
dc.subject.hlbsecondlevel | Ophthalmology | en_US |
dc.subject.hlbsecondlevel | Oncology and Hematology | en_US |
dc.subject.hlbsecondlevel | Obstetrics and Gynecology | en_US |
dc.subject.hlbsecondlevel | Neurosciences | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Obstetrics and Gynecology and Department of Pathology, University of Michigan School of Medicine, USA | en_US |
dc.contributor.affiliationum | Department of Obstetrics and Gynecology and Department of Pathology, University of Michigan School of Medicine, USA | en_US |
dc.contributor.affiliationum | Department of Obstetrics and Gynecology and Department of Pathology, University of Michigan School of Medicine, USA | en_US |
dc.contributor.affiliationum | Department of Obstetrics and Gynecology and Department of Pathology, University of Michigan School of Medicine, USA | en_US |
dc.identifier.pmid | 2535999 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/28069/1/0000512.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/S0090-8258(89)80038-1 | en_US |
dc.identifier.source | Gynecologic Oncology | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.